How Huntington Disease Medications Work

Huntington disease is a progressive neurodegenerative disorder characterized by chorea, dystonia, cognitive decline, psychiatric symptoms, and weight loss. The primary goal of medication treatment is to manage these symptoms and improve quality of life.

Gold Standard: Tetrabenazine

• Tetrabenazine is the gold standard for treating chorea in Huntington disease.
• It works by depleting vesicular monoamine transporter 2 (VMAT2), which reduces dopamine release and subsequent chorea.
• Tetrabenazine has been shown to improve chorea severity and reduce motor symptoms in patients with Huntington disease.

Alternatives: Dopaminergic Modulators

• Amantadine, Ropinirole, and Levodopa/Carbidopa are alternative medications used to manage chorea and other motor symptoms in Huntington disease.
• These medications work by modulating dopamine levels or activity in the brain, which can help alleviate chorea and dystonia.
• However, their efficacy may be lower compared to tetrabenazine, and they may have more side effects.

Important Considerations

When selecting a medication for Huntington disease, it is essential to consider the individual patient's symptoms, medical history, and potential side effects. Regular monitoring of motor function and cognitive assessments can help guide treatment decisions and optimize symptom management.